Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Athersys, Inc. stock logo
ATHX
Athersys
$0.00
$0.01
$0.01
$1.99
$272K-0.91.77 million shs233,798 shs
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$3.45
+10.6%
$3.88
$2.42
$5.81
$88.63M1.1766,599 shs69,245 shs
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
$1.09
+0.9%
$1.06
$0.88
$3.39
$82.21M1.93367,270 shs219,102 shs
United-Guardian, Inc. stock logo
UG
United-Guardian
$8.26
-1.3%
$7.97
$5.79
$10.23
$37.91M0.738,810 shs16,722 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Athersys, Inc. stock logo
ATHX
Athersys
-2.22%+33.33%-32.31%-81.77%-99.46%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-2.80%+1.96%-18.11%-31.58%-9.30%
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
+1.89%+4.85%+6.93%-11.48%-14.96%
United-Guardian, Inc. stock logo
UG
United-Guardian
-0.71%+6.36%+10.44%+11.02%-16.40%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Athersys, Inc. stock logo
ATHX
Athersys
N/AN/AN/AN/AN/AN/AN/AN/A
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
1.5136 of 5 stars
3.55.00.00.00.00.80.0
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
1.1219 of 5 stars
3.54.00.00.00.60.00.0
United-Guardian, Inc. stock logo
UG
United-Guardian
2.1083 of 5 stars
0.05.01.70.01.71.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Athersys, Inc. stock logo
ATHX
Athersys
N/AN/AN/AN/A
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3.00
Buy$10.00189.86% Upside
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
3.00
Buy$4.00266.97% Upside
United-Guardian, Inc. stock logo
UG
United-Guardian
N/AN/AN/AN/A

Current Analyst Ratings

Latest UG, ETON, ATHX, and ONCY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2024
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$3.00
2/14/2024
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Athersys, Inc. stock logo
ATHX
Athersys
$146K1.86N/AN/A($1.33) per share0.00
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$31.64M2.80$0.00 per share1,004.44$0.60 per share5.75
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
N/AN/AN/AN/A$0.27 per shareN/A
United-Guardian, Inc. stock logo
UG
United-Guardian
$10.89M3.48$0.57 per share14.40$2.48 per share3.33

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Athersys, Inc. stock logo
ATHX
Athersys
-$72.53M-$2.03N/AN/AN/AN/A-223.03%N/A
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-$940K-$0.03N/AN/A-2.96%-6.21%-3.17%5/9/2024 (Estimated)
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
-$20.56M-$0.30N/AN/AN/AN/A-105.97%-72.80%5/3/2024 (Estimated)
United-Guardian, Inc. stock logo
UG
United-Guardian
$2.58M$0.5614.75N/A23.71%24.26%21.11%5/9/2024 (Estimated)

Latest UG, ETON, ATHX, and ONCY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/22/2024Q4 2023
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A$0.16+$0.16$0.16N/A$2.61 million
3/14/2024Q4 2023
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
-$0.04-$0.09-$0.05-$0.09$7.70 million$7.31 million    
3/7/2024Q4 2023
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
-$0.11-$0.04+$0.07-$0.04N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Athersys, Inc. stock logo
ATHX
Athersys
N/AN/AN/AN/AN/A
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
N/AN/AN/AN/AN/A
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
N/AN/AN/AN/AN/A
United-Guardian, Inc. stock logo
UG
United-Guardian
$0.506.05%-49.58%89.29%N/A

Latest UG, ETON, ATHX, and ONCY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/30/2024
United-Guardian, Inc. stock logo
UG
United-Guardian
Semi-Annual$0.105.8%2/9/20242/12/20242/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Athersys, Inc. stock logo
ATHX
Athersys
N/A
0.06
0.06
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
N/A
1.65
1.60
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
N/A
9.01
9.01
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A
7.99
7.19

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Athersys, Inc. stock logo
ATHX
Athersys
19.35%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
27.86%
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
6.82%
United-Guardian, Inc. stock logo
UG
United-Guardian
23.16%

Insider Ownership

CompanyInsider Ownership
Athersys, Inc. stock logo
ATHX
Athersys
0.03%
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
13.16%
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
0.10%
United-Guardian, Inc. stock logo
UG
United-Guardian
29.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Athersys, Inc. stock logo
ATHX
Athersys
2461.72 million61.70 millionNo Data
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3025.69 million22.31 millionOptionable
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
2975.42 million75.35 millionNot Optionable
United-Guardian, Inc. stock logo
UG
United-Guardian
234.59 million3.26 millionNot Optionable

UG, ETON, ATHX, and ONCY Headlines

SourceHeadline
World’s first LGBTQ+ alcohol-free brew-masters are making an impactWorld’s first LGBTQ+ alcohol-free brew-masters are making an impact
msn.com - April 26 at 12:29 PM
World Malaria Day: How climate change is worsening the spread of the diseaseWorld Malaria Day: How climate change is worsening the spread of the disease
firstpost.com - April 26 at 2:28 AM
United-Guardian (NASDAQ:UG) Could Be At Risk Of Shrinking As A CompanyUnited-Guardian (NASDAQ:UG) Could Be At Risk Of Shrinking As A Company
finance.yahoo.com - April 24 at 1:32 PM
United-Guardian (NASDAQ:UG) Coverage Initiated at StockNews.comUnited-Guardian (NASDAQ:UG) Coverage Initiated at StockNews.com
americanbankingnews.com - April 20 at 2:22 AM
War and Plunder in Eastern CongoWar and Plunder in Eastern Congo
counterpunch.org - April 17 at 1:39 AM
Spot Gold Rises As Tehran Attack Sparks Fear Of Wider Conflict: This ETF (NUGT) Tracks Gold Miners - Direxion Daily Gold Miners Index Bull 2XShares (ARCA:NUGT)Spot Gold Rises As Tehran Attack Sparks Fear Of Wider Conflict: This ETF (NUGT) Tracks Gold Miners - Direxion Daily Gold Miners Index Bull 2XShares (ARCA:NUGT)
benzinga.com - April 16 at 1:52 PM
Gold rises, oil choppy after Iran attacks IsraelGold rises, oil choppy after Iran attacks Israel
reuters.com - April 14 at 7:58 PM
Out in the World: Ugandan Constitutional Court upholds most of anti-gay lawOut in the World: Ugandan Constitutional Court upholds most of anti-gay law
ebar.com - April 8 at 2:27 PM
Hidden debt threatens economies but stronger disclosure laws helpHidden debt threatens economies but stronger disclosure laws help
ippmedia.com - April 4 at 7:45 AM
Uganda court rejects petition to overturn harsh anti-gay lawUganda court rejects petition to overturn harsh anti-gay law
theguardian.com - April 3 at 8:43 AM
Hoping For An Incorruptible AfricaHoping For An Incorruptible Africa
thenews-chronicle.com - April 2 at 9:49 AM
Milk production volume reaches 3.6bn litres by 2023Milk production volume reaches 3.6bn litres by 2023
ippmedia.com - April 1 at 1:43 PM
UN demands monitoring as 74m people face famineUN demands monitoring as 74m people face famine
ippmedia.com - April 1 at 8:43 AM
Mohammed Kudus: Ghana Midfielder Laments Debut 2023 AFCON Experience: “It Didn’t Go As Planned”Mohammed Kudus: Ghana Midfielder Laments Debut 2023 AFCON Experience: “It Didn’t Go As Planned”
yen.com.gh - March 30 at 9:10 PM
TBT acts to enhance tea industry growth, support farmersTBT acts to enhance tea industry growth, support farmers
ippmedia.com - March 30 at 9:10 PM
China, IPU collaborated extensively, especially on SDGsChina, IPU collaborated extensively, especially on SDGs
ippmedia.com - March 29 at 2:57 PM
The rainbow flag was an international beacon of hope. Republicans killed it.The rainbow flag was an international beacon of hope. Republicans killed it.
msn.com - March 29 at 2:57 PM
Experts recommend digital health system to improve servicesExperts recommend digital health system to improve services
ippmedia.com - March 28 at 11:54 PM
CUET UG 2024 Registration Pushes for Mandatory Aadhaar Details, Violates SC’s Privacy VerdictCUET UG 2024 Registration Pushes for Mandatory Aadhaar Details, Violates SC’s Privacy Verdict
newsclick.in - March 28 at 6:53 PM
Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
finance.yahoo.com - March 28 at 1:53 PM
United-Guardian GAAP EPS of $0.56, revenue of $10.89MUnited-Guardian GAAP EPS of $0.56, revenue of $10.89M
msn.com - March 25 at 2:39 AM
United-Guardian Reports 2023 Financial ResultsUnited-Guardian Reports 2023 Financial Results
globenewswire.com - March 22 at 9:00 AM
Today-History-Mar17Today-History-Mar17
msn.com - March 18 at 10:16 AM
Arsenal get Thomas Partey boost ahead of crucial Man City title showdownArsenal get Thomas Partey boost ahead of crucial Man City title showdown
msn.com - March 18 at 10:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Athersys logo

Athersys

NASDAQ:ATHX
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.
Eton Pharmaceuticals logo

Eton Pharmaceuticals

NASDAQ:ETON
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Oncolytics Biotech logo

Oncolytics Biotech

NASDAQ:ONCY
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
United-Guardian logo

United-Guardian

NASDAQ:UG
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.